Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA, Lonning PE (1996) Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811–814
2. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang YC, Pegoraro L, Clark SC (1990) M-07e human leukaemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145: 458–464
3. Aydiner A, Koyuncu H, Tas F, Topuz E, Disci R (2000) Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day. Int J Clin Pharmacol Res 20: 21–30
4. Battista R, Bassan R, D'Emilio A, Dragone P, Viero P, Dini E, Barbui T (1991) Short-term remission induction and consolidation therapy for adult acute myelogenous leukaemia. Hematol Oncol 9: 43–52
5. Ben-Ishay Z, Prindull G, Yankelev S, Sharon S (1990) Cumulative bone marrow stromal damage caused by X-irradiation and cytosine-arabinoside in mice. Med Oncol Tumor Pharmacother 7: 55–59
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献